Skip to main content
. 2017 Jun 1;24(6):583–599. doi: 10.5551/jat.40006

Table 4. Comparison of the analytical performances of homogeneous assays for LDL-C and HDL-C between fasting and postprandial samples of non-diseased and diseased groups.

Group Non-diseased group Diseased group
(fasting, n = 16/postprandial, n = 43)
(fasting, n = 66/postprandial, n = 43)
Manufacturer A B C D A B C D
LDL-Cha
    Mean bias (%) −1.82/0.21 −0.95/2.09 1.63/2.57 1.90/2.55 0.03/2.88 −0.29/3.13 4.57/4.16 1.25/3.71
    TEcom (%) 3.80/2.18 2.89/4.03 4.45/5.40 3.79/4.44 2.00/4.85 2.24/5.07 7.39/6.99 3.14/5.60
    CVe (%) 0.60/0.56 0.58/0.57 0.54/0.50 0.52/0.47 0.67/0.72 0.48/0.64 0.60/0.62 0.46/0.61
    CVd (%) 3.92/3.30 3.11/3.03 2.80/3.42 3.97/2.36 4.90/6.01 5.58/5.16 5.92/6.73 4.37/5.55
    graphic file with name jat-24-583-g008.jpg 3.97/3.36 3.17/3.09 2.86/3.47 4.01/2.42 4.95/6.06 5.61/5.20 5.96/6.76 4.40/5.59
    Mean bias [ECA] (%) 0.02/−0.44 0.51/0.32 0.55/0.36 0.46/−0.24 0.62/−0.07 0.88/0.91 0.72/0.20 0.67/−0.14
    TEeca (%) 7.80/7.03 6.72/6.38 6.16/7.16 8.32/4.98 10.32/11.94 11.88/11.10 12.40/13.45 9.29/11.10

HDL-Cha
    Mean bias (%) 1.78/2.79 −3.07/−2.99 −1.59/−1.38 1.23/0.65 4.10/5.74 −1.15/−2.21 0.94/−0.27 0.83/0.12
    TEcom (%) 3.96/5.27 4.57/4.49 4.07/3.87 3.76/3.17 6.58/8.22 2.65/3.71 3.43/2.76 4.35/2.65
    CVe (%) 0.61/0.62 0.49/0.65 0.50/0.65 0.58/0.60 0.64/0.74 0.57/0.61 0.75/0.64 0.57/0.72
    CVd (%) 3.40/2.47 2.57/2.21 3.29/3.58 2.98/3.23 3.69/4.64 6.04/3.21 4.79/3.74 3.93/4.14
    graphic file with name jat-24-583-g009.jpg 3.46/2.56 2.62/2.31 3.34/3.65 3.04/3.30 3.75/4.70 6.07/3.27 4.85/3.81 3.98/4.21
    Mean bias [ECA] (%) 0.72/0.33 −0.31/−0.39 0.17/0.26 −0.73/−0.78 1.43/1.04 −0.09/0.27 0.00/0.47 −0.55/−0.31
    TEeca (%) 7.50/5.35 5.45/4.92 6.72/7.41 6.69/7.25 8.78/10.25 11.99/6.68 9.51/7.94 8.35/8.56

LDL-C, low-density lipoprotein-cholesterol; CV, coefficient of variance; HDL-C, high-density lipoprotein-cholesterol; HA, homogeneous assay

Data in each cell are the calculated values for fasting (left) and postprandial (right) samples.

All parameters were calculated as described in the legend to Table 3.

A, Denka Seiken; B, Wako; C, Kyowa Medex; D, Sekisui Medical